openPR Logo
Press release

Long-Term Investors in Inari Medical, Inc. (NASDAQ: NARI) should contact the Shareholders Foundation in connection with Investigation over potential Wrongdoing

An investigation on behalf of current long term investors in Inari Medical, Inc. (NASDAQ: NARI) shares.

An investigation on behalf of current long term investors in Inari Medical, Inc. (NASDAQ: NARI) shares.

An investigation was announced on behalf of current long-term investors in shares of Inari Medical, Inc. (NASDAQ: NARI) concerning potential breaches of fiduciary duties by certain directors of Inari Medical, Inc.

Investors who are current long term investors in Inari Medical, Inc. (NASDAQ: NARI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NASDAQ: NARI stocks follows a lawsuit filed against Inari Medical, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: NARI stocks, concerns whether certain Inari Medical, Inc. directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the Southern District of New York the plaintiff alleges that, the Defendants consistently touted Inari's "record revenue," purportedly driven by "the strength in our core VTE business" while failing to disclose that a significant portion of its expenses were used to compensate medical professionals improperly for using Inari's products, and that the Company had been unlawfully compensating health care professionals in violation of the federal Anti-Kickback Statute and Civil False Claims Act and had misled investors regarding business expenses in order to conceal their illicit conduct.

Those who purchased shares of Inari Medical, Inc. (NASDAQ: NARI) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Long-Term Investors in Inari Medical, Inc. (NASDAQ: NARI) should contact the Shareholders Foundation in connection with Investigation over potential Wrongdoing here

News-ID: 3865930 • Views:

More Releases from Shareholders Foundation, Inc.

Lawsuit filed for Investors who lost money with shares of Tronox Holdings plc (NYSE: TROX)
Lawsuit filed for Investors who lost money with shares of Tronox Holdings plc (N …
An investor, who purchased shares of Tronox Holdings plc (NYSE: TROX), filed a lawsuit over alleged violations of Federal Securities Laws by Tronox Holdings plc in connection with certain allegedly false and misleading statements. Investors who purchased shares of Tronox Holdings plc (NYSE: TROX) have certain options and for certain investors are short and strict deadlines running. Deadline: November 3, 2025. NYSE: TROX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Investigation announced for Investors in Petco Health and Wellness Company, Inc. (NASDAQ: WOOF)
Investigation announced for Investors in Petco Health and Wellness Company, Inc. …
An investigation was announced for current long-term investors in shares of Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) concerning potential breaches of fiduciary duties by certain directors of Petco Health and Wellness Company, Inc. Investors who are current long term investors in Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation
Investigation announced for Long-Term Investors in RxSight, Inc. (NASDAQ: RXST) over potential Wrongdoing
Investigation announced for Long-Term Investors in RxSight, Inc. (NASDAQ: RXST) …
An investigation was announced for current long-term investors in shares of RxSight, Inc. (NASDAQ: RXST) concerning potential breaches of fiduciary duties by certain directors of RxSight, Inc. Investors who are current long term investors in RxSight, Inc. (NASDAQ: RXST) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: RXST
Tesla, Inc. (NASDAQ: TSLA) Investor Alert: Deadline in Lawsuit on October 3, 2025
Tesla, Inc. (NASDAQ: TSLA) Investor Alert: Deadline in Lawsuit on October 3, 202 …
A deadline is coming up on October 3, 2025 in the lawsuit filed for certain investors of Tesla, Inc. (NASDAQ: TSLA) over alleged securities laws violations by Tesla, Inc. Investors who purchased shares of Tesla, Inc. (NASDAQ: TSLA) have certain options and there are strict and short deadlines running. Deadline: October 3, 2025. Tesla, Inc. (NASDAQ: TSLA) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -

All 5 Releases


More Releases for Inari

Lawsuit filed for Investors who lost money with shares of Inari Medical, Inc. (N …
An investor, who purchased shares of Inari Medical, Inc. (NASDAQ: NARI), filed a lawsuit over alleged violations of Federal Securities Laws by Inari Medical, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Inari Medical, Inc. (NASDAQ: NARI) have certain options and for certain investors are short and strict deadlines running. Deadline: July 12, 2024. NASDAQ: NARI investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Investigation announced for Investors in shares of Inari Medical, Inc. (NASDAQ: …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Inari Medical, Inc. . Investors who purchased shares of Inari Medical, Inc. (NASDAQ: NARI) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Inari Medical, Inc.and directors breached their fiduciary duties and caused damage to the company and its
Investigation announced for Investors who lost money with shares of Inari Medica …
An investigation was announced over potential securities laws violations by Inari Medical, Inc. in connection with certain financial statements. Investors who purchased shares of Inari Medical, Inc. (NASDAQ: NARI), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether certain statements by Inari Medical, Inc. regarding its business, its prospects and its operations were materially false
Global Mechanical Thrombectomy Devices Market is poised to witness a 6% CAGR by …
Blood clots are a common health concern which needs an immediate medical attention. Mechanical thrombectomy devices are used in medical procedures used to treat arterial blockages caused by blood clots. The conditions which are treatable by a mechanical thrombectomy are ischemic stroke, pulmonary embolism (PE), and deep vein thrombosis (DVT). Technological Innovations and Developments in Mechanical Thrombectomy Triggers the Growth of Mechanical Thrombectomy Devices Market The global mechanical thrombectomy devices market is
Catheter-Directed Thrombolysis Market (2023-2030) Comprehensive Review With Tren …
The most recent expert intelligence report from WMR, titled "The Global Catheter-Directed Thrombolysis Market 2023: Growing Need and Opportunities" offers a sorted view of the Catheter-Directed Thrombolysis industry through an analysis of research and data gathered from various sources. This information can assist global market decision-makers in playing a significant role in having a gradual impact on the global economy. In terms of market size, market statistics, and competitive environment,
Ultrasonic Thrombectomy Device Market Growth Opportunity And Forecast 2029| Stry …
Los Angeles, United State: QY Research recently published a research report titled, "Global Ultrasonic Thrombectomy Device Research Report Market 2023". The research study presented in this report offers complete and intelligent analysis of the competition, segmentation, dynamics, and geographical advancement of the global Ultrasonic Thrombectomy Device market. It takes into account the CAGR, value, volume, revenue, production, consumption, sales, manufacturing cost, prices, and other key factors related to the global